Innovation in Enteric Vaccine Development: Addressing Bacterial Causes of Diarrhea

This fact sheet describes PATH's enteric vaccine project from a technical perspective. It includes an overview of PATH's vaccine development portfolio, research activities, and partners to support the development of effective and affordable vaccines against Shigella and enterotoxigenic Escherichia coli, the leading bacterial causes of diarrhea, for children in the developing world.

Publication date: May 2016

Innovation in Enteric Vaccine Development

767.9 KB PDF

Hard copies are not available.

View Resource